P45. Protein kinase inhibitors as modifiers of radiosensitivity in glioblastoma cells
نویسندگان
چکیده
منابع مشابه
Will kinase inhibitors make it as glioblastoma drugs?
Kinase inhibitors have emerged as effective cancer therapeutics in a variety of human cancers. Glioblastoma (GBM), the most common malignant brain tumor in adults, represents a compelling disease for kinase inhibitor therapy because the majority of these tumors harbor genetic alterations that result in aberrant activation of growth factor signaling pathways. Attempts to target the Ras-Phosphati...
متن کاملProtein kinase inhibitors as a therapeutic modality.
Most of the signal transduction pathways are mediated by protein kinases regulating every aspect of cell function. Mutations which deregulate their expression or their function or both result in cancers. Therefore, protein kinase inhibitors has become the focus of development of new therapies for cancer. Almost all 120 protein tyrosine kinases are involved in signaling, whereas only a handful o...
متن کاملOrganometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.
A new metal-containing scaffold for the design of protein kinase inhibitors is introduced. Key feature is a 3-(2-pyridyl)-1,8-naphthalimide "pharmacophore chelate ligand" which is designed to form two hydrogen bonds with the hinge region of the ATP-binding site and is at the same time capable of serving as a stable bidentate ligand through C-H-activation at the 4-position of the electron-defici...
متن کاملSynthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase
Objective(s) Inhibitors of p38 MAP kinase are considered as suitable target in the treatment of inflammatory diseases such as rheumatoid arthritis and bowel inflammatory diseases. The development of 5-alkylthio-1-aryl-2-(4-pyridinyl) triazoles as inhibitors of p38 MAP kinase is described. These are analogues of 4- pyridinyl imidazole p38 MAP kinase inhibitor reported by Merck Research Laborator...
متن کاملEGFR inhibitors and glioblastoma tumor initiating cells 1 DIFFERENT RESPONSE OF HUMAN GLIOMA TUMOR-INITIATING CELLS TO EGFR KINASE INHIBITORS
Fabrizio Griffero (1, 2), Antonio Daga (1), Daniela Marubbi (2), Maria Cristina Capra (1), Alice Melotti (1, 2), Alessandra Pattarozzi (2), Monica Gatti (2), Adriana Bajetto (2), Carola Porcile (2), Federica Barbieri (2), Roberto E. Favoni (1), Michele Lo Casto (1), Gianluigi Zona (3), Renato Spaziante (3), Tullio Florio (2)* and Giorgio Corte (1, 2)* *) Joint Last Authors 1) Department of Tran...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Cancer Supplements
سال: 2006
ISSN: 1359-6349
DOI: 10.1016/j.ejcsup.2006.04.105